Associate Professor of Surgery, UCSF
General Surgery
Dr. Laura J. Esserman, MD
|
|
Give Review
Doctor Laura J. Esserman, MD is an expert in the field of General Surgery. She went to Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care She received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors", "Fellow (FACS)" and "Super Doctor". Dr. Laura J. Esserman is a published doctor and has 99 publications published. The lastest was: 'Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.' She accepts all Medicare patients.
Publications
- Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
- A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor Malignancies.
- Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management.
- The impact of Breast mass on outcomes of total skin-sparing mastectomy and immediate tissue expander-based Breast reconstruction.
- Mammographic Changes After Oncoplastic Reduction Mammoplasty.
- The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer.
- Expression profiling of circulating tumor cells in metastatic Breast cancer.
- Preoperative Breast Pain Predicts Persistent Breast Pain and Disability Following Breast Cancer Surgery.
- SIS.NET: A randomized controlled trial evaluating a web-based system for symptom management after treatment of Breast cancer.
- Randomized trial of drain antisepsis after mastectomy and immediate prosthetic Breast reconstruction.
- Total skin-sparing mastectomy and immediate Breast reconstruction: an evolution of technique and assessment of outcomes.
- Immediate Implant-Based Breast Reconstruction following Total Skin-Sparing Mastectomy: Defining the Risk of Preoperative and Postoperative Radiation Therapy for Surgic...
- Fifty years of age-based screening: time for a new risk-based screening approach.
- Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657).
- Addressing overdiagnosis and overtreatment in Cancer: a prescription for change.
- Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with Breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).
- Impact of Total Skin-Sparing Mastectomy Incision Type on Reconstructive Complications Following Radiation Therapy.
- Accelerated Approval for Pertuzumab in the Neoadjuvant Setting: Winds of Change?
- Immediate Implant-Based Breast Reconstruction Following Total Skin-Sparing Mastectomy In Women With A History Of Augmentation Mammoplasty: Assessing The Safety Profile.
- Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
- Real-Time Measurement of Functional Tumor Volume by MRI to Assess Treatment Response in Breast Cancer Neoadjuvant Clinical Trials: Validation of the Aegis SER Software...
- Characteristics of individuals with Breast cancer rearrangements in BRCA1 and BRCA2.
- Patient-Reported Outcomes and Satisfaction After Total Skin-Sparing Mastectomy and Immediate Expander-Implant Reconstruction.
- Optimized Breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy.
- Evolving Paradigm for Imaging, Diagnosis, and Management of DCIS.
- Screening: Biology dictates the fate of young women with Breast cancer.
- Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
- Patient preferences regarding intraoperative versus external beam radiotherapy following Breast-conserving surgery.
- Making Better Doctors: A Survey of Premedical Interns Working as Health Coaches.
- Impact of ductal Carcinoma in situ terminology on patient treatment preferences.
- Cost-effectiveness analysis of intraoperative radiation therapy for early-stage Breast cancer.
- Total Skin-Sparing Mastectomy in BRCA Mutation Carriers.
- Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement.
- The Athena Breast Health Network: developing a rapid learning system in Breast cancer prevention, screening, treatment, and care.
- Feasibility of Performing Total Skin-Sparing Mastectomy in Patients With Prior Circumareolar Mastopexy or Reduction Mammoplasty Incisions.
- Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials.
- Total Skin-Sparing Mastectomy: A Systematic Review of Oncologic Outcomes and Postoperative Complications.
- Reply: the effects of acellular dermal matrix in expander-implant Breast reconstruction after total skin-sparing mastectomy.
- Will early detection for Breast cancer ever work?
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping.
- Elevated Levels of Proliferating and Recently Migrated Tumor-associated Macrophages Confer Increased Aggressiveness and Worse Outcomes in Breast Cancer.
- Xenografts faithfully recapitulate Breast cancer-specific gene expression patterns of parent primary Breast tumors.
- Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure.
- Physician Behaviors Surrounding the Implementation of Decision and Communication Aids in a Breast Cancer Clinic: a Qualitative Analysis of Staff Intern Perceptions.
- The impact of an electronic health questionnaire on symptom management and behavior reporting for Breast cancer survivors.
- Adoption, acceptability, and accuracy of an online clinical trial matching website for Breast cancer.
- The effects of acellular dermal matrix in expander-implant Breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study.
- Locally advanced Breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.
- Outcomes after Total Skin-sparing Mastectomy and Immediate Reconstruction in 657 Breasts.
- Evaluating the Feasibility of Extended Partial Mastectomy and Immediate Reduction Mammoplasty Reconstruction as an Alternative to Mastectomy.
- Accelerating identification and regulatory approval of investigational Cancer drugs.
- Impact of mammographic screening on the detection of good and poor prognosis Breast cancers.
- Outcome of long term active surveillance for estrogen receptor-positive ductal Carcinoma in situ.
- Breast Cancer Special Feature: Leukocyte composition of human Breast cancer.
- Elevated PCNA+ tumor-associated macrophages in Breast cancer are associated with early recurrence and non-Caucasian ethnicity.
- Proposals for uniform collection of biospecimens from neoadjuvant Breast cancer clinical trials: timing and specimen types.
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Canc...
- Biologic markers determine both the risk and the timing of recurrence in Breast cancer.
- Characterizing the impact of 25Â years of DCIS treatment.
- Intraoperative frozen section analysis of sentinel lymph nodes in Breast cancer patients: a meta-analysis and single-institution experience.
- Proliferating macrophages associated with high grade, hormone receptor negative Breast cancer and poor clinical outcome.
- Impact of chemotherapy on postoperative complications after mastectomy and immediate Breast reconstruction.
- Application of screening principles to the reconstructed Breast.
- Bacteriologic features of surgical site infections following Breast surgery.
- Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for Breast cancer.
- Improved surgical outcomes for Breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
- The UCSC Cancer Genomics Browser.
- When informed, all women do not prefer Breast conservation.
- Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients.
- Sensitivity to input variability of the Adjuvant! Online Breast cancer prognostic model.
- Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in Breast cancer?
- Invasive Breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.
- Estrogen receptor-negative Breast cancer is less likely to arise among lipophilic statin users.
- Multiplexed cell signaling analysis of human Breast cancer applications for personalized therapy.
- Statement of the science concerning locoregional treatments after preoperative chemotherapy for Breast cancer: a National Cancer Institute conference.
- Optimizing the total skin-sparing mastectomy.
- Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity...
- Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with Breast cancer.
- Ductal Carcinoma in situ in BRCA mutation carriers.
- Type and duration of exogenous hormone use affects Breast cancer histology.
- Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal Carcinoma in situ.
- Magnetic resonance imaging captures the biology of ductal Carcinoma in situ.
- Breast cancer growth prevention by statins.
- Clinical trials are required to prove the chemopreventive worth of statins.
- A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular Breast cancer subtypes.
- Breast cancer risk assessment and prevention: a framework for shared decision-making consultations.
- Statins: health-promoting agents show promise for Breast cancer prevention.
- MRI measurements of Breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.
- Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
- Safety of immediate transverse rectus abdominis myocutaneous Breast reconstruction for patients with locally advanced disease.
- Internal mammary sentinel lymph node mapping for invasive Breast cancer: implications for staging and treatment.
- Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.
- Evaluation of Breast cancer risk assessment techniques: a cost-effectiveness analysis.
- Clonality of lobular Carcinoma in situ and synchronous invasive lobular Carcinoma.
- Cyclooxygenase-2 expression is related to nuclear grade in ductal Carcinoma in situ and is increased in its normal adjacent epithelium.
- Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.
Schools
Stanford University
Stanford University Med Center
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Fellow (FACS)
- Super Doctor
Education
-
Stanford University -
Stanford University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1679537971 | |
| NPPES Provider LastName | ESSERMAN | |
| NPPES Provider FirstName | LAURA | |
| NPPES Provider ZIPCode | 941430001 | |
| NPPES Provider State | CA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 79.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679537971 |
| Last Name Of The Provider | ESSERMAN |
| First Name Of The Provider | LAURA |
| View All |
Similar Doctors
|
|
Dr. Wen T. Shen, MD |
|
|
Dr. Timothy A. Chuter, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Oscar J. Jackson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana L. Farmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles W. Hoopes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hubert Luu, MD |
|
|
Dr. Audrey H. Choi, MD |
|
|
Dr. Isabelle T. Chumfong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin M. Howard, MD |
|
|
Dr. Lauren C. Ritz, MD |